Evidence map›Paper›PMID 27080031›Full record

ArticleScientific reports2016

A novel anesthesia regime enables neurofunctional studies and imaging genetics across mouse strains.

Marija M Petrinovic, Georges Hankov, Aileen Schroeter, Andreas Bruns, Markus Rudin, Markus von Kienlin, Basil Künnecke, Thomas Mueggler

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Zero Echo TimeMetabolites · 2021
    Article
  10. Article
  11. Article
  12. A Comparison of Ketamine or Etomidate Combined with Xylazine for Intraperitoneal Anesthesia in Four Mouse Strains.Journal of the American Association for Laboratory Animal Science : JAALAS · 2020
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Marija M PetrinovicRoche Pharmaceutical Research &Early Development, Neuroscience Discovery, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland.
Georges HankovInstitute for Biomedical Engineering, University and ETH Zurich, Wolfgang-Pauli-Strasse 27, 8093 Zurich, Switzerland.
Aileen SchroeterInstitute for Biomedical Engineering, University and ETH Zurich, Wolfgang-Pauli-Strasse 27, 8093 Zurich, Switzerland.
Andreas BrunsRoche Pharmaceutical Research &Early Development, Neuroscience Discovery, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland.
Markus RudinInstitute for Biomedical Engineering, University and ETH Zurich, Wolfgang-Pauli-Strasse 27, 8093 Zurich, Switzerland.
Markus von KienlinRoche Pharmaceutical Research &Early Development, Neuroscience Discovery, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland.
Basil KünneckeRoche Pharmaceutical Research &Early Development, Neuroscience Discovery, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland.
Thomas MuegglerRoche Pharmaceutical Research &Early Development, Neuroscience Discovery, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Grenzacherstrasse 124, 4070 Basel, Switzerland.
Roche (Switzerland) · CHETH Zurich · CHInstitute for Biomedical Engineering · CH

Funding

Medical Research Council MR/N026063/1
6 · The paper itself

Abstract

Functional magnetic resonance imaging (fMRI) has revolutionized neuroscience by opening a unique window that allows neurocircuitry function and pathological alterations to be probed non-invasively across brain disorders. Here we report a novel sustainable anesthesia procedure for small animal neuroimaging that overcomes shortcomings of anesthetics commonly used in rodent fMRI. The significantly improved preservation of cerebrovascular dynamics enhances sensitivity to neural activity changes for which it serves as a proxy in fMRI readouts. Excellent cross-species/strain applicability provides coherence among preclinical findings and is expected to improve translation to clinical fMRI investigations. The novel anesthesia procedure based on the GABAergic anesthetic etomidate was extensively validated in fMRI studies conducted in a range of genetically engineered rodent models of autism and strains commonly used for transgenic manipulations. Etomidate proved effective, yielded long-term stable physiology with basal cerebral blood flow of ~0.5 ml/g/min and full recovery. Cerebrovascular responsiveness of up to 180% was maintained as demonstrated with perfusion- and BOLD-based fMRI upon hypercapnic, pharmacological and sensory stimulation. Hence, etomidate lends itself as an anesthetic-of-choice for translational neuroimaging studies across rodent models of brain disorders.

Indexed as

AnesthesiaMagnetic Resonance ImagingNeuroimagingAnesthetics, InhalationAnimalsBrainCerebrovascular CirculationEtomidateIsofluraneMedetomidineMiceRatsSpecies SpecificityAnesthetics, InhalationEtomidateIsofluraneMedetomidine

Identifiers

PMID27080031
PMCPMC4832200
OpenAlexW2340439758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.